More on DXR
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $11.09 |
|
|||
| Open | $10.60 | ||||
| 52 Wk High | $8.90 | ||||
| 52 Wk Low | $7.00 | ||||
| Day High | $10.60 | ||||
| Day Low | $10.60 | ||||
| P/E | N/A | ||||
| EPS | $-1.70 | ||||
| Volume | 485 | ||||
- Form DEF 14A DAXOR CORP For: Jun 03
- Daxor receives US patent for remote blood volume monitoring technology
- Daxor Corporation Receives U.S. Patent for Breakthrough Remote Blood Volume Monitor
- Form NT NPORT-P DAXOR CORP For: Mar 31
- Form 40-8F-2/A DAXOR CORP
- Form 40-17F2 DAXOR CORP Filed by: DAXOR CORP
- Form 40-17F2 DAXOR CORP Filed by: DAXOR CORP
- Daxor Leverages MedAxiom CV Transforum Spring’26 to Accelerate Commercial Adoption of Blood Volume Analysis
- Form 4 DAXOR CORP For: Apr 08 Filed by: Feldschuh Michael Richard
- Daxor launches blood volume testing program at Ohio cardiology center
Entities mentioned with DXR
- FDA | View Related Stories »
- Dividend | View Related Stories »
- Jefferies & Co | View Related Stories »
- Definitive Agreement | View Related Stories »
- H.C. Wainwright | View Related Stories »
- Maxim Group | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Show More...
